This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Dan Hyo Kim: Innovator in Radiation Sensitivity Enhancement
Introduction
Dan Hyo Kim is a notable inventor based in Goseong-gun, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on enhancing radiation sensitivity, which is crucial for improving the effectiveness of cancer therapies.
Latest Patents
Dan Hyo Kim holds a patent for a composition aimed at enhancing radiation sensitivity. The patent, titled "Composition for enhancing radiation sensitivity comprising PI4K isozyme inhibitor," describes a composition that includes a PI4K isozyme inhibitor as an active ingredient. This invention demonstrates an excellent effect in reducing the viability of cancer cells and overcoming radiation resistance during irradiation. By inhibiting the PI4K isozyme, the composition suppresses and delays DNA damage repair induced by radiation, making it a valuable adjuvant in radiation sensitivity and an assisting agent in anticancer treatment. He has 1 patent to his name.
Career Highlights
Dan Hyo Kim is affiliated with Seoul National University, where he conducts his research and development activities. His work has garnered attention for its potential to improve cancer treatment outcomes through innovative approaches to radiation therapy.
Collaborations
Dan Hyo Kim collaborates with esteemed colleagues, including Jean Ny Kwon and Ji Min Park. Their combined expertise contributes to advancing research in the field of cancer treatment and radiation sensitivity.
Conclusion
Dan Hyo Kim is a pioneering inventor whose work in enhancing radiation sensitivity has the potential to transform cancer treatment methodologies. His contributions to the field are significant and reflect a commitment to improving patient outcomes through innovative research.